|
|
|
Volumn 9, Issue 1, 2006, Pages 28-31
|
|
Metabolic Profiling - IBC's Inaugural Meeting. Using metabolics to accelerate drug discovery and development. 14-15 November 2005, Durham, NC, USA
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATAZANAVIR;
BIOLOGICAL MARKER;
ENZYME INHIBITOR;
GLUCOSE;
IMATINIB;
INSULIN;
MULTIENZYME COMPLEX;
PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;
PIOGLITAZONE;
RILUZOLE;
ROSIGLITAZONE;
TRANSKETOLASE;
AMYOTROPHIC LATERAL SCLEROSIS;
BIOTECHNOLOGY;
CHOLESTEROL SYNTHESIS;
CITRIC ACID CYCLE;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
DISEASE MARKER;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG SYNTHESIS;
DRUG TARGETING;
DYSLIPIDEMIA;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GAS CHROMATOGRAPHY;
GENE EXPRESSION PROFILING;
GENE OVEREXPRESSION;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INSULIN RELEASE;
INSULIN RESISTANCE;
MASS SPECTROMETRY;
MEDICAL TECHNOLOGY;
METABOLIC DISORDER;
METABOLOMICS;
NONHUMAN;
VALIDATION PROCESS;
ANIMALS;
BIOLOGICAL MARKERS;
COMPUTATIONAL BIOLOGY;
DRUG INDUSTRY;
FINANCING, GOVERNMENT;
GAS CHROMATOGRAPHY-MASS SPECTROMETRY;
GENE EXPRESSION PROFILING;
HUMANS;
METABOLISM;
NATIONAL INSTITUTES OF HEALTH (U.S.);
SOCIETIES, SCIENTIFIC;
UNITED STATES;
|
|
EID: 31144448656
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (0)
|
